ResearcherRadboud University Medical CenterActive in the last 2 years
Valentyna Kryklyva
Matched on ORCID iD 0000-0002-1020-6606; OpenAlex author ID A5077816263. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2021: 2 papers · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 6
- Germline Pathogenic Variants in Patients with Pancreatic Ductal Adenocarcinoma and Extra-Pancreatic Malignancies: A Nationwide Database Analysis. Co-author DOI 10.1016/j.modpat.2025.100709↗
- Automatic quantification of tumor-stroma ratio as a prognostic marker for pancreatic cancer. Co-author DOI 10.1371/journal.pone.0301969↗
- Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic. First author DOI 10.1080/14728222.2022.2021397↗
- Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemistry. Co-author DOI 10.1136/gutjnl-2021-326033↗
- Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications. Co-author DOI 10.1136/gutjnl-2020-320726↗
- Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions. Co-author DOI 10.3390/cancers13133119↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lodewijk A.A. Brosens · 6 shared papers, 2021–2025 · strength 1.07
- Paper Germline Pathogenic Variants in Patients with Pancreatic Ductal Adenocarcinoma and Extra-Pancreatic Malignancies: A Nat… DOI 10.1016/j.modpat.2025.100709↗
- Paper Automatic quantification of tumor-stroma ratio as a prognostic marker for pancreatic cancer. DOI 10.1371/journal.pone.0301969↗
- Paper Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemist… DOI 10.1136/gutjnl-2021-326033↗
- Claudio Luchini · 4 shared papers, 2021–2022 · strength 0.58
- Paper Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemist… DOI 10.1136/gutjnl-2021-326033↗
- Paper Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic. DOI 10.1080/14728222.2022.2021397↗
- Paper Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecula… DOI 10.1136/gutjnl-2020-320726↗
- Irıs D. Nagtegaal · 2 shared papers, 2022–2025 · strength 0.45
- Paper Germline Pathogenic Variants in Patients with Pancreatic Ductal Adenocarcinoma and Extra-Pancreatic Malignancies: A Nat… DOI 10.1016/j.modpat.2025.100709↗
- Paper Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemist… DOI 10.1136/gutjnl-2021-326033↗
- Rita Teresa Lawlor · 3 shared papers, 2021–2022 · strength 0.38
- Paper Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic. DOI 10.1080/14728222.2022.2021397↗
- Paper Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecula… DOI 10.1136/gutjnl-2020-320726↗
- Paper Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Op… DOI 10.3390/cancers13133119↗
- Aldo Scarpa Scarpa · 3 shared papers, 2021–2022 · strength 0.38
- Paper Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic. DOI 10.1080/14728222.2022.2021397↗
- Paper Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecula… DOI 10.1136/gutjnl-2020-320726↗
- Paper Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Op… DOI 10.3390/cancers13133119↗
- Paola Mattiolo · 2 shared papers, 2021–2022 · strength 0.27
- Paper Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic. DOI 10.1080/14728222.2022.2021397↗
- Paper Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Op… DOI 10.3390/cancers13133119↗
- Andrea Mafficini · 2 shared papers, 2021–2022 · strength 0.27
- Paper Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic. DOI 10.1080/14728222.2022.2021397↗
- Paper Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Op… DOI 10.3390/cancers13133119↗
- Michèle Milella · 2 shared papers, 2021–2022 · strength 0.27
- Paper Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic. DOI 10.1080/14728222.2022.2021397↗
- Paper Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Op… DOI 10.3390/cancers13133119↗
- Michael Johannes Pflüger · 1 shared paper, 2025 · strength 0.25
- Pierpaolo Vendittelli · 1 shared paper, 2024 · strength 0.24
- E. Smeets · 1 shared paper, 2024 · strength 0.24
- Geert J. S. Litjens · 1 shared paper, 2024 · strength 0.24
- Caroline Sophie Verbeke · 1 shared paper, 2024 · strength 0.24
- Giuseppe Malleo · 2 shared papers, 2021 · strength 0.22
- Paper Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecula… DOI 10.1136/gutjnl-2020-320726↗
- Paper Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Op… DOI 10.3390/cancers13133119↗
- Roberto Salvia · 2 shared papers, 2021 · strength 0.22
- Paper Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecula… DOI 10.1136/gutjnl-2020-320726↗
- Paper Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Op… DOI 10.3390/cancers13133119↗
- Martijn W.J. Stommel · 1 shared paper, 2022 · strength 0.20
- Vincenzo Corbo · 1 shared paper, 2022 · strength 0.16
- Volkan N. Adsay · 1 shared paper, 2021 · strength 0.11
- Deyali Chatterjee · 1 shared paper, 2021 · strength 0.11
- Laura DeLong Wood · 1 shared paper, 2021 · strength 0.11
- Antonio Pea · 1 shared paper, 2021 · strength 0.11
- Seung‐Mo Hong · 1 shared paper, 2021 · strength 0.11
- Giovanni Marchegiani · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.